Market Place
Sourcing Support
FDA Approves Luye Pharma`s ERZOFRI For Schizophrenia Treatment
28 Jul 2024 //
PR NEWSWIRE
Luye Pharma partners with Korea-based Myung In Pharm
07 Feb 2024 //
BIOSPECTRUM ASIA
Luye, Duopharma to expand accessibility of cholesterol management products
05 Apr 2023 //
BIOSPECTRUM ASIA
US FDA approves Luye Pharma’s schizophrenia treatment Rykindo
16 Jan 2023 //
PHARMACEUTICAL TECHNOLOGY
Luye Pharma enters into new partnership with ICI Pakistan for mental healthcare
27 Sep 2022 //
BIOSPECTRUMASIA
Boan Biotech to Present the Pre-clinical Data at World Bispecific Summit
26 Sep 2021 //
PRNEWSWIRE
Boan Biotech to Start PhII Clinical Trial in US Against SARS-CoV-2
16 Jun 2021 //
PRESS RELEASE
Luye Pharma and Towa Pharmaceutical Enter Strategic Collaboration
18 Feb 2021 //
PRNASIA
Luye Pharma’s Antidepressant Drug LY03005 Completes Primary Endpoint Observation
22 Dec 2020 //
FIRSTWORDPHARMA
Luye Pharma’s Antidepressant Drug LY03005 Completes Primary Endpoint Observation
22 Dec 2020 //
FIRSTWORDPHARMA
Luye Pharma Starts a Phase III Clinical Study for Denosumab Injection (LY01011)
15 Dec 2020 //
LUYE
PharmaMar & Luye Pharma have started a clinical trial with lurbinectedin
04 Dec 2020 //
PRESS RELEASE
Luye Pharma & Distriphil Enter Exclusive Distribution PartnershipPhilippines
26 Nov 2020 //
BUSINESSINSIDER
Ocumension strengthens pipeline for posterior segment eye diseases in China
30 Oct 2020 //
BIOSPECTRUMASIA
Luye Pharma Signs Two Agreements in Latin America, Global Business System
11 Sep 2020 //
PRNNEWSWIRE
Luye Pharma`s Rivastigmine Transdermal Patch Receives Market Approval in China
08 Jun 2020 //
PRESS RELEASE
Luye Pharma Enters Distribution and Marketing Partnerships in South Korea
02 Jun 2020 //
PRNASIA
Luye Pharma raises awareness on mental health
01 Jun 2020 //
BIOSPECTRUMASIA
Luye Pharma Grants Exclusive Promotion Rights to Moksha8, Deepening
14 May 2020 //
PRNEWSWIRE
Luye Pharma Group Selects LifeSphere® Signal and Risk Management
22 Apr 2020 //
PR NEWSWIRE
US FDA accepts Luye`s NDA filing for antidepressant drug, LY03005
05 Mar 2020 //
PHARMABIZ
Cipla share price rises on distribution agreement for antipsychotic drug
10 Feb 2020 //
BUSINESSWIRE
Luye Pharma Grants Cipla Medpro Exclusive Distribution & Mkt Rights Seroquel®
10 Feb 2020 //
PR NEWSWIRE
Cipla share price rises on distribution agreement for antipsychotic drug
10 Feb 2020 //
BUSINESSWIRE
Luye Pharma Grants Cipla Medpro Exclusive Distribution & Mkt Rights Seroquel®
10 Feb 2020 //
PR NEWSWIRE
China grants priority review to Luye Pharma`s schizophrenia drug
04 Jan 2020 //
BIOSPECTRUMASIA
Luye Pharma Submits NDA in the U.S. for Its Antidepressant Drug LY03005
27 Dec 2019 //
PR NEWSWIRE
Luye Pharma`s LY03004 Manufacturing Facility Successfully Passes U.S. FDA
04 Nov 2019 //
PR NEWSWIRE
Luye Pharma`s anti-depression drug to start clinical trials in Japan
22 Aug 2019 //
BIOSPECTRUMASIA
Taiwan National Health Insurance Approves Epclusa(R) (sofosbuvir/velpatasvir
29 May 2019 //
PR NEWSWIRE
LUYE SUBMITS NDA FOR SCHIZOPHRENIA, BIPOLAR DISORDER THERAPY
01 Apr 2019 //
BIOCENTURY
Luye Pharma`s Rykindo® Expected to Be the First Chinese Innovative Drug approval
28 Mar 2019 //
PRASIA
Yantai`s MabPlex Raises $59 Million To Expand CDMO Services
21 Jan 2019 //
SEEKING ALPHA
Luye Pharma Reaches Strategic Partnership with AZ
18 Jan 2019 //
PR NEWSWIRE
Luye Pharma`s Risperidone ER Reached Final Stage of NDA Process
01 Jan 2019 //
BIOSPACE
Luye Pharma`s Goserelin Acetate ER Microspheres Start Ph III in China
06 Sep 2018 //
PR NEWSWIRE
Luye Pharma Well Positioned with approval of New Indication for Seroquel XR
23 Jul 2018 //
PR NEWSWIRE
Luye Pharma receives China approval for CNS drug
23 Jul 2018 //
BIOSPECTRUM
How Luye Will Use Seroquel to Expand in Emerging Markets
07 Jun 2018 //
PR NEWSWIRE
LUYE pharma Joins US Firm to Develop Immuno-oncology Treatments
30 May 2018 //
BIOSPECTRUM
AstraZeneca sheds Seroquel rights
08 May 2018 //
PARMA TIMES
AstraZeneca sells off foreign rights to Seroquel
07 May 2018 //
BIOPHARMADIVE
